...

CCO Independent Conference Coverage


conference image

2009 Interscience Conference on Antimicrobial Agents and Chemotherapy*

September 12-15, 2009 | San Francisco, California

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.


Mouse over track for more info

Expert Highlights

These audio files are in mp3 format. To listen to the audio, simply click "Download Audio." You must be logged on to the clinicaloptions.com site to listen to or download the mp3 files.

Eric S. Daar, MD headshot Eric S. Daar, MD, discusses several reports from ICAAC 2009 on HIV-1 testing and treatment strategies. (9 minutes) Download Audio
Sally Hodder, MD headshot Sally Hodder, MD, discusses results of the substudies of the GRACE study, an important treatment trial looking at sex and race subpopulations of treatment-experienced patients. (5 minutes) Download Audio

Disclosures – Audio Expert Highlights

Eric S. Daar, MD, has disclosed that he has received grants for research support from Abbott Laboratories, Gilead Sciences, GlaxoSmithKline, Merck, and Pfizer and has served as a consultant/advisor for Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, and Tibotec.

Sally Hodder, MD, has disclosed that she has received grants for research support form Tibotec and Gilead Sciences and that she serves on advisory boards for Bristol-Myers Squibb, Gilead Sciences, and Tibotec. Her spouse is a former employee of Merck and owns stock in that company.

Jointly sponsored by USF Health and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

Capsule Summary:

Antiretroviral Pregnancy Registry: In Utero Exposure to Tenofovir Not Associated With Increased Prevalence of Congenital Abnormalities

Prevalence of birth defects among infants exposed to tenofovir in utero similar to overall prevalence of birth defects observed with exposure to all antiretrovirals in APR and also similar to prevalence in general population.

CLICK HERE TO KEEP READING

CLICK HERE FOR RELATED CAPSULE SUMMARIES